Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $21.22 Analyst target: $35.00 Upside: 64.94%
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
See the full interactive analysis & chart →Informational only — not investment advice.